TY - JOUR
T1 - Spatial distribution of transgenic protein after gene electrotransfer to porcine muscle
AU - Spanggaard, Iben
AU - Corydon, Thomas Juhl
AU - Hojman, Pernille
AU - Gissel, Hanne
AU - Dagnaes-Hansen, Frederik
AU - Jensen, Thomas G.
AU - Gehl, Julie
PY - 2012
Y1 - 2012
N2 - Abstract Gene electrotransfer is an effective nonviral technique for delivery of plasmid DNA into tissues. From a clinical perspective, muscle is an attractive target tissue as long-term, high-level transgenic expression can be achieved. Spatial distribution of the transgenic protein following gene electrotransfer to muscle in a large animal model has not yet been investigated. In this study, 17 different doses of plasmid DNA (1-1500 μg firefly luciferase pCMV-Luc) were delivered in vivo to porcine gluteal muscle using electroporation. Forty-eight hours post treatment several biopsies were obtained from each transfection site in order to examine the spatial distribution of the transgenic product. We found a significantly higher luciferase activity in biopsies from the center of the transfection site compared to biopsies taken adjacent to the center, 1 and 2 cm along muscle fiber orientation (p
AB - Abstract Gene electrotransfer is an effective nonviral technique for delivery of plasmid DNA into tissues. From a clinical perspective, muscle is an attractive target tissue as long-term, high-level transgenic expression can be achieved. Spatial distribution of the transgenic protein following gene electrotransfer to muscle in a large animal model has not yet been investigated. In this study, 17 different doses of plasmid DNA (1-1500 μg firefly luciferase pCMV-Luc) were delivered in vivo to porcine gluteal muscle using electroporation. Forty-eight hours post treatment several biopsies were obtained from each transfection site in order to examine the spatial distribution of the transgenic product. We found a significantly higher luciferase activity in biopsies from the center of the transfection site compared to biopsies taken adjacent to the center, 1 and 2 cm along muscle fiber orientation (p
U2 - 10.1089/hgtb.2012.173
DO - 10.1089/hgtb.2012.173
M3 - Journal article
C2 - 23157397
VL - 23
SP - 387
EP - 392
JO - Human Gene Therapy. Methods
JF - Human Gene Therapy. Methods
SN - 1946-6536
IS - 6
ER -